Dan Hartman

Dr. Dan Hartman leads a team that provides technical expertise to the foundation’s disease-focused teams on managing product development pipelines, from late discovery through registration and life-cycle planning. In addition to offering guidance in the areas of quantitative sciences, pharmacology, chemical manufacturing, and regulatory strategy, the Integrated Development team makes grants that benefit numerous foundation strategies, most notably in the areas of regulatory systems, pharmacology-focused model-based drug development, big data programs, novel formulations (including for pediatrics), and low-cost manufacturing. Dan joined the foundation in his current role in 2012, and from 2016 to 2018 he simultaneously served as interim director of the Malaria team. He remains a senior advisor to the Malaria team.

Dan has extensive management and pharmaceutical development experience, including four years as president and CEO of Great Lakes

Drug Development, a consulting company that provided strategic and operational support for drug development projects. Earlier, he served as senior vice president of product development at deCODE genetics, executive director of Pfizer Global Research and Development, and vice president of global clinical development at Esperion Therapeutics and held clinical research positions at Eli Lilly and Company. He has also been a consultant to the biopharmaceutical venture capital community and serves on or advises several for profit and nonprofit boards.

From 2016 to 2019, Dan served on the advisory council of the National Institutes of Health’s National Center for the Advancement of Translational Sciences (NCATS) and the review board of the Cures Acceleration Network at NCATS. He is a past president of the American Society for Clinical Pharmacology and Therapeutics and has received numerous awards, including National Inventor of the Year from the Intellectual Property Owners Association in the United States.

Dan received a bachelor’s degree from Calvin University and a medical degree from Wayne State University. He trained in internal medicine and completed a fellowship in pulmonary medicine at Indiana University, where he also served as chief medical resident.